Processa Pharmaceuticals, Inc. Increase (Decrease) in Income Taxes Payable
Processa Pharmaceuticals, Inc. (PCSA) reported Increase (Decrease) in Income Taxes Payable of -$200 for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2017-11-20
- Processa Pharmaceuticals, Inc. increase (decrease) in income taxes payable for the quarter ending 2015-12-31 was $25.00.
- Processa Pharmaceuticals, Inc. increase (decrease) in income taxes payable for the quarter ending 2015-09-30 was $25.00, a 0.00% change year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in income taxes payable for the quarter ending 2015-06-30 was $25.00, a 0.00% change year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in income taxes payable for the quarter ending 2015-03-31 was $25.00, a 0.00% change year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in income taxes payable for fiscal 2015 was $100.00.
- Processa Pharmaceuticals, Inc. increase (decrease) in income taxes payable for fiscal 2013 was $50.00, a 0.00% change from fiscal 2012.
- Processa Pharmaceuticals, Inc. increase (decrease) in income taxes payable for fiscal 2012 was $50.00.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month | Increase (Decrease) in Income Taxes Payable 12 month as first filed | Increase (Decrease) in Income Taxes Payable 27 month | Increase (Decrease) in Income Taxes Payable 30 month | Increase (Decrease) in Income Taxes Payable 33 month |
|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | -$200.00 10-Q · filed 2017-11-20 | |||||||
| 2015-12-31 | $25.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $50.00 derived: sum of 2 quarters · filed 2017-09-25 | $75.00 derived: sum of 3 quarters · filed 2017-09-25 | $100.00 10-K · filed 2017-09-25 | ||||
| 2015-09-30 | $25.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $50.00 derived: sum of 2 quarters · filed 2017-09-08 | $75.00 10-Q · filed 2017-09-08 | |||||
| 2015-06-30 | $25.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | $50.00 10-Q · filed 2017-08-30 | ||||||
| 2015-03-31 | $25.00 10-Q · filed 2017-08-07 | |||||||
| 2014-09-30 | $25.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | $50.00 derived: sum of 2 quarters · filed 2015-12-01 | $75.00 10-Q · filed 2015-12-01 | $200.00 derived: sum of 4 quarters · filed 2015-12-01 | ||||
| 2014-06-30 | $25.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | $50.00 10-Q · filed 2015-08-19 | $175.00 derived: sum of 3 quarters · filed 2015-08-19 | $200.00 derived: sum of 4 quarters · filed 2015-08-19 | ||||
| 2014-03-31 | $25.00 10-Q · filed 2015-05-15 | $150.00 derived: sum of 2 quarters · filed 2015-05-15 | $175.00 derived: sum of 3 quarters · filed 2015-05-15 | |||||
| 2013-12-31 | $125.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $150.00 derived: sum of 2 quarters · filed 2015-04-14 | $50.00 10-K · filed 2015-04-14 | -$50.00 10-K · filed 2014-03-27 | $100.00 10-K · filed 2014-03-27 | |||
| 2013-09-30 | $25.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-08 | -$75.00 10-Q · filed 2013-11-08 | $75.00 10-Q · filed 2013-11-08 | |||||
| 2013-06-30 | -$100.00 10-Q/A · filed 2013-09-06 | $50.00 10-Q/A · filed 2013-09-06 | ||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $0.00 derived: sum of 2 quarters · filed 2014-03-27 | $50.00 10-K · filed 2014-03-27 | |||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-08 | $50.00 10-Q · filed 2013-11-08 | ||||||
| 2012-06-30 | $50.00 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |